Commodore Capital is a healthcare-focused investment firm that uses a science-driven approach to invest in innovative biopharmaceutical companies, targeting small-cap public equities and late-stage private therapeutics businesses. Founded in 2019, it is based in New York and registered with the SEC as an investment adviser.
65% of their portfolio is in Biotech & Life Sciences. Deal activity decreased year-over-year (1 deal in the last 12 months vs 2 prior). Average disclosed round size is $177.7M (across 17 rounds with reported amounts).
Portfolio
17
Fund Size
—
Top Stage
Series B
Last 12 Mo
1
Team
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
17 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| OOllin | Series B | $330M | Jun 2026 |
 Ollin Biosciences | Series B | $330M | Jan 2026 |
| SSAB Biotherapeutics, Inc. | Series B | $175M | Jul 2025 |
 Crescent Biopharma | Growth | $200M | Jun 2025 |
 Damora Therapeutics | Unknown | $284.9M | Jan 2025 |
 Avalo Therapeutics | Unknown | $185M | Jan 2024 |
 ADARx Pharmaceuticals | Series C | $200M | Aug 2023 |
| AAdarx | Series C | $46M | Jan 2023 |
 Shoreline Biosciences | Series B | $43M | Apr 2021 |
 EnLiven Therapeutics | Series B | $85M | Dec 2020 |
 Kronos Bio | Series A | $105M | Jan 2020 |
| EEnliven | Series A | $55M | Jan 2020 |
 Oruka Therapeutics | Growth | $275M | — |
 Alto Neuroscience | Series C | $120M | — |
 Adverum Biotechnologies | Unknown | $127.5M | — |
 Agenus | Unknown | $340M | — |
 IDRx | Series B | $120M | — |
Top Co-Investors
RA Capital Management7 shared
Logos Capital5 shared
Perceptive Advisors5 shared
Fairmount Funds Management5 shared
T. Rowe Price5 shared
OrbiMed5 shared
Blackstone Inc.4 shared
Cormorant Asset Management4 shared
Vivo Capital4 shared
The Invus Group, LLC4 shared
Deep Track Capital3 shared
Redmile Group3 shared
Rock Springs Capital3 shared
RTW Investments, LP2 shared
BVF Partners L.P.2 shared
Wellington Management2 shared
Braidwell LP2 shared
Frazier Life Sciences2 shared
Last updated: 7 October 2026